Form 4 · Filed May 21, 2026, 08:20 PM UTC
COAG/Hemab Therapeutics Holdings, Inc.
RA CAPITAL MANAGEMENT, L.P. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2026 | P | buy | 996 | $25 | $24,840 | 6,376,968 |
| May 19, 2026 | P | buy | 3,802 | $25 | $94,936 | 6,375,972 |
Source: SEC EDGAR raw filing ↗ · Accession 0001231919-26-000521